Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1

NCT00015171 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
NIH
Sponsor class

Conditions

Interventions

Sponsor

National Institute on Drug Abuse (NIDA)

Collaborators